Key points are not available for this paper at this time.
Abstract The partial hydrogenation of alkynes into alkenes constitutes a pivotal chemical transformation in the synthesis of fine chemicals, pharmaceuticals, and polymers. Nevertheless, the extant industrial catalyst falls short of achieving a felicitous equilibrium between its catalytic potency and selectivity. Herein, triphenylphosphine (PPh 3 ) modified Pd/Al 2 O 3 catalysts are fabricated through a “one‐pot” process, which achieve highly selective hydrogenation of alkynes at room temperature. PPh 3 plays a dual role—as a reducing agent and a ligand. Kinetic and characterization studies reveal PPh 3 alters H 2 activation from homolytic to heterolytic cleavage, which facilitate the formation of alkene. Moreover, PPh 3 can also optimize the reaction microenvironment, achieving the reduced self‐poisoning of alkyne and promoted desorption of alkene. In the realm of alkyne hydrogenation, our philosophy encompasses a global optimization of active sites, ligand systems, and reaction microenvironmental. This method steers the course of catalyst development for other reactions beyond the field of alkyne hydrogenation.
Wang et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: